We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.79B
AUM Growth
+$1.37B
(+16%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
2,579
New
256
Increased
680
Reduced
638
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$31.5M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$20.5M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
+$13.5M |
| 4 |
eBay
EBAY
|
+$12.8M |
| 5 |
Korn Ferry
KFY
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$20.9M |
| 2 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$15.2M |
| 3 |
JPMorgan Chase
JPM
|
+$13.2M |
| 4 |
Pediatrix Medical
MD
|
+$12.5M |
| 5 |
Viatris
VTRS
|
+$9.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Industrials | 13.03% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 11.32% |
| 5 | Energy | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Vanguard Growth ETF
VUG
$216B
| $210K | ﹤0.01% |
13,626
+1,962
| +17% | +$29K |
|
|
AZ
1077
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| $210K | ﹤0.01% |
11,735
+585
| +5% | +$10.5K |
|
1078
Cabot Corp
CBT
$4.72B
| $209K | ﹤0.01% |
4,070
| – | – |
|
|
WBMD
1079
DELISTED
WebMD Health Corp.
WBMD
| $209K | ﹤0.01% |
5,323
-1,538
| -22% | -$55.5K |
|
|
JAH
1080
DELISTED
JARDEN CORPORATION
JAH
| $209K | ﹤0.01% |
5,112
-932
| -15% | -$33.8K |
|
1081
National Fuel Gas
NFG
$7.74B
| $208K | ﹤0.01% |
2,918
+338
| +13% | +$23.5K |
|
|
TIVO
1082
DELISTED
Tivo Inc
TIVO
| $208K | ﹤0.01% |
10,600
+2,000
| +23% | +$36.6K |
|
|
RENX
1083
DELISTED
RELX N.V.
RENX
| $208K | ﹤0.01% |
14,997
+643
| +4% | +$8.61K |
|
|
TELN
1084
DELISTED
TELENOR ASA
TELN
| $207K | ﹤0.01% |
2,902
| – | – |
|
1085
Prologis
PLD
$138B
| $206K | ﹤0.01% |
5,619
| – | – |
|
1086
Dorman Products
DORM
$4.22B
| $205K | ﹤0.01% |
3,659
+835
| +30% | +$42K |
|
1087
Monro
MNRO
$536M
| $205K | ﹤0.01% |
3,651
| – | – |
|
|
VOLC
1088
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $205K | ﹤0.01% |
9,422
-328
| -3% | -$7.26K |
|
1089
Invesco Financial Preferred ETF
PGF
$676M
| $202K | ﹤0.01% |
12,000
| – | – |
|
|
LM
1090
DELISTED
Legg Mason, Inc.
LM
| $201K | ﹤0.01% |
4,631
+998
| +27% | +$38.7K |
|
|
HIBB
1091
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $201K | ﹤0.01% |
3,008
+272
| +10% | +$16.6K |
|
1092
Textron
TXT
$15.6B
| $200K | ﹤0.01% |
5,450
-2,440
| -31% | -$74.9K |
|
|
RAVN
1093
DELISTED
Raven Industries Inc
RAVN
| $200K | ﹤0.01% |
4,868
-225
| -4% | -$8.1K |
|
1094
FMC
FMC
$1.41B
| $199K | ﹤0.01% |
3,058
| – | – |
|
|
ELNK
1095
DELISTED
EarthLink Holdings Corp.
ELNK
| $199K | ﹤0.01% |
39,334
-5,250
| -12% | -$26.8K |
|
1096
iShare MSCI Eurozone ETF
EZU
$9.46B
| $198K | ﹤0.01% |
4,792
| – | – |
|
1097
Dentsply Sirona
XRAY
$2.68B
| $198K | ﹤0.01% |
4,093
+2,593
| +173% | +$121K |
|
1098
Expro Ltd
XPRO
$1.8B
| $197K | ﹤0.01% |
1,217
| – | – |
|
|
AXA
1099
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $197K | ﹤0.01% |
7,079
+2,965
| +72% | +$82.5K |
|
1100
El Paso Energy Capital Trust I
EP.PRC
$223M
| $196K | ﹤0.01% |
3,500
| – | – |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2013 Portfolio in Review
As of Q4 2013, Glenmede Trust held 2,579 positions worth $9.79B, up 16% from $8.42B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust's Q4 2013 filing shows 256 new, 680 increased, 638 reduced and 183 closed positions. Its largest new stake was Korn Ferry: 518,057 shares worth $13.5M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $20.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Glenmede Trust's largest Q4 2013 buy was Korn Ferry: 518,057 shares worth $13.5M.
- Glenmede Trust added most to Stryker in Q4 2013, an estimated $31.5M increase.
- Glenmede Trust's biggest Q4 2013 reduction was JPMorgan Chase, cutting an estimated $13.2M.
- Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q4 2013, selling an estimated $20.9M.
- Glenmede Trust's ten largest holdings make up 16% of its $9.79B portfolio in Q4 2013.
- Glenmede Trust opened 256 new positions and closed 183 in Q4 2013.
- Glenmede Trust's portfolio value rose 16% quarter-over-quarter to $9.79B.
Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.